Cite

HARVARD Citation

    Colomba, E. et al. (2022). Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinoma. Journal of cachexia, sarcopenia and muscle. 13 (5), pp. 2405-2416. [Online]. 
  
Back to record